LifeStance Expects Fiscal Year 2024 Revenues Of $1.19B-$1.24B, Versus Consensus Of $1.20B, With Center Margin of $345M-$365M, And Adjusted EBITDA Of $80M-$90M; The Company Expects To Generate Positive Free Cash Flow For 2024
Portfolio Pulse from Benzinga Newsdesk
LifeStance Health Group, Inc. (LFST) forecasts its fiscal year 2024 revenues to be between $1.19B and $1.24B, aligning closely with the consensus estimate of $1.20B. The company also anticipates a center margin of $345M-$365M and an adjusted EBITDA of $80M-$90M, with expectations to generate positive free cash flow for the year.
February 28, 2024 | 11:16 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeStance Health Group, Inc. (LFST) expects FY2024 revenues of $1.19B-$1.24B, in line with consensus estimates, and projects positive free cash flow.
LifeStance's forecast aligns closely with consensus estimates, indicating management's confidence in the company's growth trajectory and operational efficiency. The projection of positive free cash flow is a significant indicator of financial health and operational efficiency, likely to be viewed positively by investors. This news is directly related to LFST and is critical for investors, as it provides insights into the company's future financial performance and stability.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100